Literature DB >> 15164385

Hemophagocytic syndrome associated with retinoic acid syndrome in acute promyelocytic leukemia.

J García-Suárez1, H Bañas, I Krsnik, D De Miguel, E Reyes, C Burgaleta.   

Abstract

A 56-year-old woman with an acute promyelocytic leukemia (APL) developed a severe all-trans-retinoic (ATRA) syndrome on day 17 of treatment. Shortly after, she presented a picture of pancytopenia, hepatosplenomegaly, increased triglycerides, ferritin, and liver enzymes. A bone marrow biopsy showed abundant macrophages and no evidence of leukemia. Tests for secondary hemophagocytic syndrome (HPS) were negative. A diagnosis of HPS was made. Treatment with dexamethasone and high-dose immunoglobulins was unsuccessful. Consolidation chemotherapy with idarubicin and ATRA rapidly reversed the HPS. The HPS in this patient could be related to the release of macrophage-stimulating cytokines by APL cells during ATRA syndrome. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164385     DOI: 10.1002/ajh.20071

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

Review 1.  Transplantation in rare lymphoproliferative and histiocytic disorders.

Authors:  Alexis Cruz-Chacon; John Mathews; Ernesto Ayala
Journal:  Cancer Control       Date:  2014-10       Impact factor: 3.302

2.  Hemophagocytic lymphohistiocytosis with MUNC13-4 gene mutation or reduced natural killer cell function prior to onset of childhood leukemia.

Authors:  Tamara Y Chang; Julie Jaffray; Bruce Woda; Peter E Newburger; G Naheed Usmani
Journal:  Pediatr Blood Cancer       Date:  2010-12-15       Impact factor: 3.167

3.  ATRA Induced Reactive Hemophagocytosis: a Case Report.

Authors:  Monica Sharma; Jasmita Dass; Seema Tyagi
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.